“…Most studies (32/46) reported factors on ACS use [ 22 , 24 , 40 – 47 , 49 , 50 , 52 , 53 , 55 – 57 , 59 , 61 – 64 , 68 – 70 , 73 , 74 , 77 – 81 ], while comparatively fewer reported on tocolytics (13/46) [ 24 , 40 , 44 , 51 , 53 , 54 , 57 , 59 , 66 , 67 , 73 , 76 , 80 ], magnesium sulphate for fetal neuroprotection (9/46) [ 23 , 42 , 58 , 60 , 65 , 72 , 75 , 80 , 82 ], or antibiotics for PPROM use (5/46) [ 48 , 57 , 70 , 71 , 73 ], with some studies reported use on more than one intervention, with mostly reported ACS and tocolytics at the same time [ 24 , 40 , 42 , 44 , 53 , 57 , 59 , 70 , …”